Fluid retention with thiazolidinediones: does the mechanism influence the outcome?
Lindenfeld
Joann
J
Masoudi
Frederick A
FA
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004487:Edema / Q000139:chemically induced; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077154:Rosiglitazone; D013599:Systole / Q000187:drug effects; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D016277:Ventricular Function, Left / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone